FHD-609

• Target:

  PROTACs|||Epigenetic Reader Domain|||Others

• Related Pathways:

  Chromatin/Epigenetic|||PROTAC|||Others

• Bioactivity:

  FHD-609, an inhibitor and degrader of BRD9 (bromodomain-containing protein 9), targets the ncBAF complex and is useful for researching a broad spectrum of cancers with mutations in a BAF complex subunit. When used alongside Telomelysin or INO5401, FHD-609 could be effective in treating adrenocortical carcinoma (ACC) [1] [2].

• Smiles:

  C(N1CCC2(CN(C2)C=3C=C4C(=CC3)CN(C4=O)[C@@H]5C(=O)NC(=O)CC5)CC1)C6CCN(CC7=C(OC)C=C(C=C7OC)C=8C=9C(=CN=C(C9)N%10CCC%10)C(=O)N(C)C8)CC6

• Molecular Formula:

  C47H56N8O6

• Molecular Weight:

  829

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2676211-64-4